Category - Pharmaceutical Industry

• Peptides: The FDA opens a ‘Pandora’s box’
• Tracking harm of compounded drugs
• MERCY OPENS RETAIL PHARMACIES TO THE PUBLIC AT ROGERS AND FORT SMITH HOSPITALS
• Monthly costs to rise for millions as subsidy program comes to end
• Quebec will keep digital prescripti­ons
• ‘Game changer’ drug turns cancer’s defenses against itself
• ‘Blue capsules’ emerge as latest prescripti­on drug abuse threat
• Ignoring peptides market dangerous
• WHY KNOWING YOUR MEDICATION MATTERS
• She Waited F.or The Court, Cancer Did Not
• Pharmacist calls for GP referrals
• ‘This is revolution­ary’: Guidelines take aim at syndrome affecting nearly 90% of U.S. adults
• Dangerous weight loss ‘shortcut’
• UAE 2nd nation in the world to clear medicine for cholestero­l
• Cardiac arrest risk of the patients on antidepres­sants
• Children in UK suffering as Euro rules shut them out of clinical trial programmes
• Screening guidelines get an update amid rise in colorectal cancer in younger adults
• US generics drag weighs on Sun Pharma
• Cracking the cancer code: study proves inherited genes shape how tumours grow
• Saving kids from brain tumors
• Biotech startup tries to tackle obesity, but it’s not another GLP-1
• Ross is vegan, doesn’t drink and exercises daily. So how could he end up with advanced bowel cancer at just 43?
• Viagra could be a secret weapon to fight breast cancer, Israeli scientists discover
• Briton is first in world to receive cancer therapy
• Call to unlock medicines
• New hope for skin cancer surfaces
• Ignoring peptides market dangerous
• Ignoring peptides market dangerous
• Trump admin ending Medicare drug subsidy
• Trump admin ending Medicare drug subsidy
• Trump admin ending Medicare drug subsidy
• COMPOUND
• Saving lives
• Saving lives